A groundbreaking study has sparked alarm across the globe, suggesting that vaping—often marketed as a safer alternative to smoking—may carry severe health risks, including heart disease, organ failure, and dementia.

Conducted by Dr. Maxime Boidin at Manchester Metropolitan University, this first-of-its-kind research challenges long-held assumptions about e-cigarettes and has been widely covered by mainstream outlets.

While the complete data is yet to be published, the preliminary findings are raising urgent questions about the safety of vaping, a habit embraced by millions worldwide.

According to a report from The Mirror, the study indicates that vaping could be as dangerous—if not more so—than traditional cigarette smoking.

Unlike smoking, which involves periodic breaks to light a new cigarette, vaping allows for continuous use, potentially leading to higher exposure to nicotine and other harmful substances.

Dr. Boidin highlighted the presence of chemicals like propylene glycol, vegetable glycerine, and flavoring agents in vape liquids, which may contribute to oxidative stress, cell death, and damage to artery walls.

These factors, he warned, could escalate the risk of serious conditions such as dementia, heart disease, and organ failure.

The Express echoed these concerns, emphasizing the study’s claim that vaping impairs blood flow in ways similar to smoking.

This restricted circulation, combined with inflammation caused by nicotine and metals in vaping liquids, may have long-term consequences for cognitive health and organ function.

The outlet noted that the research, set to conclude in March 2025, could reshape public health policies if its findings hold.

CNN, a leading U.S. news source, has previously reported on the intricate connection between cardiovascular health and brain function, lending context to these new findings.

A 2024 CNN article detailed how heart disease risk factors—like high blood pressure and cholesterol—can damage small blood vessels in the brain, increasing the likelihood of dementia.

The vaping study’s suggestion of heart disease as a side effect aligns with this established link, hinting at a dual threat to both heart and mind.

The BBC has also covered related research, such as a 2019 study showing how heart disease can lead to cognitive decline over time.

While that study focused on coronary heart disease rather than vaping, its findings underscore the plausibility of the Manchester research.

Impaired blood flow, a common thread in both investigations, emerges as a critical mechanism driving these deadly side effects.

Meanwhile, Reuters has reported on the broader rise of vaping-related health concerns, including cases of respiratory failure and lung damage.

Though the Manchester study shifts the focus to heart, organ, and brain health, it builds on this growing body of evidence that e-cigarettes may not be the harmless alternative once promised.

The outlet’s past coverage of vaping’s popularity—5.1 million users in the UK alone, according to the Office for National Statistics—underscores the potential scale of this public health issue.